Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis

References

• Daver N, McClain K, Allen CE, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017;123(17):3229–3240.
   PubMed Web of Science ®Google Scholar
• Arico M, Janka G, Fischer A. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996;10:197–203.
   PubMed Web of Science ®Google Scholar
• Janka G, Imashuku S, Elinder G, et al. Infection- and malignancy- associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998;12(2):435–444.
   PubMed Web of Science ®Google Scholar
• Filipovich AH, Chandrakasan S. Pathogenesis of hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 2015;29(5):895–902.
   PubMed Web of Science ®Google Scholar
• George M. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;5:69–86.
   PubMedGoogle Scholar
• Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Progr. 2013;2013(1):605–611.
   PubMedGoogle Scholar
• Filipovich AH. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program. 2009;2009(1):127–131.
   Google Scholar
• Janka G. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983;140(3):221–230.
   PubMed Web of Science ®Google Scholar
• Rosado FGN, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013;139(6):713–727.
   PubMed Web of Science ®Google Scholar
• Allen CE, Mcclain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. ASH Educ Progr B. 2015;2015:177–182.
   Google Scholar
• Brisse E, Matthys P, Wouters CH. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol. 2016;174(2):175–187.
   PubMed Web of Science ®Google Scholar
• Henter J, Elinder G, Soder O, et al. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand. 1991;80(4):428–435.
   PubMed Web of Science ®Google Scholar
• Lehmberg K, Nichols KE, Henter J-I, et al. Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies. Haematologica. 2015;100(8):997–1004.
   PubMed Web of Science ®Google Scholar
• Siddaiahgari SR, Agarwal S. Hemophagocytic lymphohistiocytosis: a review. J. Blood Disord. Transfus. 2016;7:1–7.
   Google Scholar
• Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908–2914.
   PubMed Web of Science ®Google Scholar
• George M. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J. Blood Med. 2014;5:69–86.
   PubMedGoogle Scholar
• Henter J, Horne A, Arico M et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
   PubMed Web of Science ®Google Scholar
• Henter JI, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol. 1997;28(5):342–347.
   PubMedGoogle Scholar
• Trottestam H, Horne A, Aricò M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118(17):4577–4584.
   PubMed Web of Science ®Google Scholar
• Bergsten E, Horne AC, Aricó M, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-Term results of the cooperative HLH-2004 study. Blood. 2017;130(25):2728–2738.
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang W, Hu L, et al. Multi-center study of DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. 56th ASH Annual Meeting; 2014 December 6–9; San Franciso, CA; Abstr 2748.
   Google Scholar
• Brito-Zerón P, Kostov B, Moral-Moral P, et al. Prognostic factors of death in 151 adults with hemophagocytic syndrome: etiopathogenically driven analysis. Mayo Clin Proc Innov Qual Outcomes 2018;2(3):267–276.
   PubMedGoogle Scholar
• Li F, Yang Y, Jin F, et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis. 2015;10(1):20.
   PubMedGoogle Scholar
• Hayden A, Park S, Giustini D, et al. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev. 2016;30(6):411–420.
   PubMed Web of Science ®Google Scholar
• Lam MSH, Pharm D. A guide to clinically relevant drug interactions in oncology. J Oncol Pharm. Pract. 2003;9:45–85.
   Google Scholar
• Superfin D, Iannucci AA, Davies AM. Commentary: oncologic drugs in patients with organ dysfunction: a summary. The Oncol. 2007;12(9):1070–1083.
   PubMed Web of Science ®Google Scholar
• Hendrayana T, Wilmer A, Kurth V, et al. Anticancer dose adjustment for patients with renal and hepatic dysfunction: from scientific evidence to clinical application. Sci Pharm. 2017;85(1):8.
   Web of Science ®Google Scholar
• Rosée PL, Horne AC, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133:2465–2477.
   PubMed Web of Science ®Google Scholar
• Ehl S, Astigarraga I, von Bahr Greenwood T, et al. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society. J Allergy Clin Immunol Pract. 2018;6(5):1508–1517.
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383(9927):1503–1516.
   PubMed Web of Science ®Google Scholar
• Rivière S, Galicier L, Coppo P, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med. 2014;127(11):1118–1125.
   PubMed Web of Science ®Google Scholar
• Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89(4):484–492.
   PubMed Web of Science ®Google Scholar